RNA-Seq is proving to be a valuable tool for the investigation of known and novel transcripts affecting cell development, disease status or disease mechanisms. Being able to address a range of questions, from differential expression to differential splicing, offers researchers the ability to gain greater insight into changes in gene expression during disease initiation, progression, treatment and the development of drug resistance.
In this webinar, Dr Christopher Jones, Research Fellow at the Brighton and Sussex Medical School (BSMS), UK, will discuss novel findings from a recent RNA-Seq project performed by OGT. Dr Jones has a keen interest in the effect of RNA stability on post-transcriptional control of gene expression during development, miRNAs as diagnostic biomarkers in human cancer, and the control of RNA stability in human cancer.
Using Drosophila melanogaster as a model organism to investigate the control of gene expression via mRNA degradation, Dr Jones will describe the range of novel and interesting findings regarding the number of upregulated and downregulated genes in different mutants and the degree to which gene expression of these genes change.
Attend this Webinar to learn about:
• Understanding the range of information that can be gained from
• The control of gene expression via mRNA degradation
• How OGT’s interactive report enables simple and rapid
understanding of RNA-Seq data without the need for
in-house bioinformatics support
Dr Gerald Martin